Rights and permissions
About this article
Cite this article
Natalizumab shows potential in Crohn's disease. Inpharma Wkly. 1542, 11 (2006). https://doi.org/10.2165/00128413-200615420-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200615420-00020